05/28/2025
4:26 PM | Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:26 PM | HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:27 PM | LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:27 PM | MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:27 PM | Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:27 PM | Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
8:35 AM | BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/10/2025
3:06 PM | Rigel Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2025
3:07 PM | Rigel Pharmaceuticals (Filer)
| Form DEFA14A | |
04/10/2025
3:10 PM | Rigel Pharmaceuticals (Filer)
| Form ARS | |
03/27/2025
8:16 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RIGL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/19/2025
7:55 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
7:56 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
7:56 PM | Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
7:56 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
7:56 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:41 PM | Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/10/2025
4:42 PM | Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:22 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:18 PM | ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
12:42 PM | Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
7:26 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:27 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:27 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:27 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
2:40 PM | Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
2:41 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
2:43 PM | Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
2:58 PM | Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/04/2025
3:39 PM | Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:30 PM | Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:20 PM | Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
3:21 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:45 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
5:47 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:49 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:38 PM | Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
01/13/2025
7:15 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:01 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
7:01 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
7:01 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
8:33 AM | Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G | |
11/07/2024
3:22 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:01 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
7:36 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:33 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:30 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2024
11:15 PM | Rigel Pharmaceuticals (Filer)
| Form EFFECT | |
Free RIGL Stock Alerts